Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slavin

Showing results (201-210 of 523) with videos related to

Pageof 53
Sort By:
Open Forum Infectious Diseases|January 12, 2026
Differences in Clinical Outcomes Among Patients With Mold FungemiaAdam G Stewart, Kevin B Laupland, Felicity Edwards, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Antibiotiki|September 1, 1978
[Increase in the oleandomycin distribution coefficient at the extraction stage by using electron carrier-acceptors]M V Ostrovskiĭ, E D Etingov, A A Slavin, et al.
Antibiotiki|February 1, 1982
[Admixture effect on oleandomycin phosphate solubility in organic solvents]A A Slavin, I Z Brunshteĭn, E D Etingov, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 25, 2013
A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive diseaseB W Teh, A S Khot, S J Harrison, et al.
British Journal of Haematology|December 24, 2005
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*Karin A Thursky, Leon J Worth, John F Seymour, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysisBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipientsM A Slavin, R R Bindra, C A Gleaves, et al.
Antibiotiki|July 1, 1978
[Components of a native solution that displace the equilibrium distribution of oleandomycin during extraction]A A Slavin, E D Etingov, M V Ostrovskiĭ, et al.
Antibiotiki|April 1, 1981
[Extraction and spectrophotometric method for the quantitative determination of oleandomycin]A A Slavin, E D Etingov, A V Prokopovich, et al.
Pageof 53

Showing results (201-210 of 523) with videos related to

Sort By:
Pageof 53
Open Forum Infectious Diseases|January 12, 2026
Differences in Clinical Outcomes Among Patients With Mold FungemiaAdam G Stewart, Kevin B Laupland, Felicity Edwards, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Antibiotiki|September 1, 1978
[Increase in the oleandomycin distribution coefficient at the extraction stage by using electron carrier-acceptors]M V Ostrovskiĭ, E D Etingov, A A Slavin, et al.
Antibiotiki|February 1, 1982
[Admixture effect on oleandomycin phosphate solubility in organic solvents]A A Slavin, I Z Brunshteĭn, E D Etingov, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 25, 2013
A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive diseaseB W Teh, A S Khot, S J Harrison, et al.
British Journal of Haematology|December 24, 2005
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*Karin A Thursky, Leon J Worth, John F Seymour, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysisBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipientsM A Slavin, R R Bindra, C A Gleaves, et al.
Antibiotiki|July 1, 1978
[Components of a native solution that displace the equilibrium distribution of oleandomycin during extraction]A A Slavin, E D Etingov, M V Ostrovskiĭ, et al.
Antibiotiki|April 1, 1981
[Extraction and spectrophotometric method for the quantitative determination of oleandomycin]A A Slavin, E D Etingov, A V Prokopovich, et al.
Pageof 53